La gravidanza in donna HIV positiva: 6 Anni di attività del Centro di Riferimento Regionale

Translated title of the contribution: Pregnancy in HIV-positive women: 6 Years of activity of the Regional Reference Center

M. Bernardon, F. De Seta, G. P. Maso, V. Cescutti, M. Olivuzzi, I. Redaelli, S. Alberico

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Aim. With this study, we wanted to evaluate HIV-positive pregnant mothers followed at the HIV Reference Center of Friuli Venezia Giulia and to describe obstetric treatment aimed at identifying vertical transmission factors and at undertaking a correct diagnostic-therapeutic approach to this patient group. The data include a large case series from the European Collaborative Study on HIV in Pregnancy, in which our facility is a collaborating center. Methods. The protocol includes the administration of personalized antiretroviral therapy to seropositive patients at the first visit. An elective caesarean section is performed at 38 weeks gestation. Antiretroviral therapy is continued in the neonate. Breastfeeding is prohibited. Results. From 1998 to 2002, 28 pregnant mothers with HIV infection were followed. Most patients came from out of region and had acquired the infection through heterosexual intercourse with a serodiscordant partner. In 1 in 3 patients, a diagnosis of seropositivity was made during pregnancy. One case of vertical transmission was observed. Conclusion. When appropriate prevention measures are instituted, the percentage of vertical transmission of infection can be reduced to less than 1% in Europe today. An important part of this effort is early screening for HIV infection in pregnancy. Other fundamental measures are the institution of antiretroviral therapy starting from the first weeks of pregnancy, monitoring of pregnancy at a tertiary reference center, intravenous administration of therapies before caesarean section, possibly not during labor and with the membrane intact. Equally important factors are neonatal therapy, adequate pediatric monitoring after the infant is born and discontinuation of breast-feeding.

Original languageItalian
Pages (from-to)435-445
Number of pages11
JournalMinerva Ginecologica
Volume57
Issue number4
Publication statusPublished - Aug 2005

Fingerprint

HIV
Pregnancy
Breast Feeding
Cesarean Section
Therapeutics
HIV Infections
Vertical Infectious Disease Transmission
Mothers
Heterosexuality
Intravenous Administration
Obstetrics
Newborn Infant
Pediatrics
Membranes
Infection

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Bernardon, M., De Seta, F., Maso, G. P., Cescutti, V., Olivuzzi, M., Redaelli, I., & Alberico, S. (2005). La gravidanza in donna HIV positiva: 6 Anni di attività del Centro di Riferimento Regionale. Minerva Ginecologica, 57(4), 435-445.

La gravidanza in donna HIV positiva : 6 Anni di attività del Centro di Riferimento Regionale. / Bernardon, M.; De Seta, F.; Maso, G. P.; Cescutti, V.; Olivuzzi, M.; Redaelli, I.; Alberico, S.

In: Minerva Ginecologica, Vol. 57, No. 4, 08.2005, p. 435-445.

Research output: Contribution to journalArticle

Bernardon, M, De Seta, F, Maso, GP, Cescutti, V, Olivuzzi, M, Redaelli, I & Alberico, S 2005, 'La gravidanza in donna HIV positiva: 6 Anni di attività del Centro di Riferimento Regionale', Minerva Ginecologica, vol. 57, no. 4, pp. 435-445.
Bernardon, M. ; De Seta, F. ; Maso, G. P. ; Cescutti, V. ; Olivuzzi, M. ; Redaelli, I. ; Alberico, S. / La gravidanza in donna HIV positiva : 6 Anni di attività del Centro di Riferimento Regionale. In: Minerva Ginecologica. 2005 ; Vol. 57, No. 4. pp. 435-445.
@article{f7adb820b5e549af8c37372eed459191,
title = "La gravidanza in donna HIV positiva: 6 Anni di attivit{\`a} del Centro di Riferimento Regionale",
abstract = "Aim. With this study, we wanted to evaluate HIV-positive pregnant mothers followed at the HIV Reference Center of Friuli Venezia Giulia and to describe obstetric treatment aimed at identifying vertical transmission factors and at undertaking a correct diagnostic-therapeutic approach to this patient group. The data include a large case series from the European Collaborative Study on HIV in Pregnancy, in which our facility is a collaborating center. Methods. The protocol includes the administration of personalized antiretroviral therapy to seropositive patients at the first visit. An elective caesarean section is performed at 38 weeks gestation. Antiretroviral therapy is continued in the neonate. Breastfeeding is prohibited. Results. From 1998 to 2002, 28 pregnant mothers with HIV infection were followed. Most patients came from out of region and had acquired the infection through heterosexual intercourse with a serodiscordant partner. In 1 in 3 patients, a diagnosis of seropositivity was made during pregnancy. One case of vertical transmission was observed. Conclusion. When appropriate prevention measures are instituted, the percentage of vertical transmission of infection can be reduced to less than 1{\%} in Europe today. An important part of this effort is early screening for HIV infection in pregnancy. Other fundamental measures are the institution of antiretroviral therapy starting from the first weeks of pregnancy, monitoring of pregnancy at a tertiary reference center, intravenous administration of therapies before caesarean section, possibly not during labor and with the membrane intact. Equally important factors are neonatal therapy, adequate pediatric monitoring after the infant is born and discontinuation of breast-feeding.",
keywords = "HIV, Pregnancy, Prevention, Vertical transmission",
author = "M. Bernardon and {De Seta}, F. and Maso, {G. P.} and V. Cescutti and M. Olivuzzi and I. Redaelli and S. Alberico",
year = "2005",
month = "8",
language = "Italian",
volume = "57",
pages = "435--445",
journal = "Minerva Ginecologica",
issn = "0026-4784",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - La gravidanza in donna HIV positiva

T2 - 6 Anni di attività del Centro di Riferimento Regionale

AU - Bernardon, M.

AU - De Seta, F.

AU - Maso, G. P.

AU - Cescutti, V.

AU - Olivuzzi, M.

AU - Redaelli, I.

AU - Alberico, S.

PY - 2005/8

Y1 - 2005/8

N2 - Aim. With this study, we wanted to evaluate HIV-positive pregnant mothers followed at the HIV Reference Center of Friuli Venezia Giulia and to describe obstetric treatment aimed at identifying vertical transmission factors and at undertaking a correct diagnostic-therapeutic approach to this patient group. The data include a large case series from the European Collaborative Study on HIV in Pregnancy, in which our facility is a collaborating center. Methods. The protocol includes the administration of personalized antiretroviral therapy to seropositive patients at the first visit. An elective caesarean section is performed at 38 weeks gestation. Antiretroviral therapy is continued in the neonate. Breastfeeding is prohibited. Results. From 1998 to 2002, 28 pregnant mothers with HIV infection were followed. Most patients came from out of region and had acquired the infection through heterosexual intercourse with a serodiscordant partner. In 1 in 3 patients, a diagnosis of seropositivity was made during pregnancy. One case of vertical transmission was observed. Conclusion. When appropriate prevention measures are instituted, the percentage of vertical transmission of infection can be reduced to less than 1% in Europe today. An important part of this effort is early screening for HIV infection in pregnancy. Other fundamental measures are the institution of antiretroviral therapy starting from the first weeks of pregnancy, monitoring of pregnancy at a tertiary reference center, intravenous administration of therapies before caesarean section, possibly not during labor and with the membrane intact. Equally important factors are neonatal therapy, adequate pediatric monitoring after the infant is born and discontinuation of breast-feeding.

AB - Aim. With this study, we wanted to evaluate HIV-positive pregnant mothers followed at the HIV Reference Center of Friuli Venezia Giulia and to describe obstetric treatment aimed at identifying vertical transmission factors and at undertaking a correct diagnostic-therapeutic approach to this patient group. The data include a large case series from the European Collaborative Study on HIV in Pregnancy, in which our facility is a collaborating center. Methods. The protocol includes the administration of personalized antiretroviral therapy to seropositive patients at the first visit. An elective caesarean section is performed at 38 weeks gestation. Antiretroviral therapy is continued in the neonate. Breastfeeding is prohibited. Results. From 1998 to 2002, 28 pregnant mothers with HIV infection were followed. Most patients came from out of region and had acquired the infection through heterosexual intercourse with a serodiscordant partner. In 1 in 3 patients, a diagnosis of seropositivity was made during pregnancy. One case of vertical transmission was observed. Conclusion. When appropriate prevention measures are instituted, the percentage of vertical transmission of infection can be reduced to less than 1% in Europe today. An important part of this effort is early screening for HIV infection in pregnancy. Other fundamental measures are the institution of antiretroviral therapy starting from the first weeks of pregnancy, monitoring of pregnancy at a tertiary reference center, intravenous administration of therapies before caesarean section, possibly not during labor and with the membrane intact. Equally important factors are neonatal therapy, adequate pediatric monitoring after the infant is born and discontinuation of breast-feeding.

KW - HIV

KW - Pregnancy

KW - Prevention

KW - Vertical transmission

UR - http://www.scopus.com/inward/record.url?scp=27144556988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27144556988&partnerID=8YFLogxK

M3 - Articolo

C2 - 16170288

AN - SCOPUS:27144556988

VL - 57

SP - 435

EP - 445

JO - Minerva Ginecologica

JF - Minerva Ginecologica

SN - 0026-4784

IS - 4

ER -